(Q31791590)

3 July 2017

1 reference

title

Cancer cachexia: a therapeutic approach (English)

1 reference

3 July 2017

Argilés JM

1

1 reference

3 July 2017

Meijsing SH

2

1 reference

3 July 2017

Pallarés-Trujillo J

3

1 reference

3 July 2017

Guirao X

4

1 reference

3 July 2017

López-Soriano FJ

5

1 reference

3 July 2017

1 January 2001

1 reference

Medicinal Research Reviews

3 July 2017

1 reference

3 July 2017

21

1 reference

3 July 2017

1

1 reference

3 July 2017

83-101

1 reference

The metabolic basis of cancer cachexia

3 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Nutritional assessment and patient outcome during oncological therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Protein-calorie undernutrition in hospitalized cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

The role of cytokines in muscle wasting: its relation with cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Body-composition changes in patients who gain weight while receiving megestrol acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Effect of megestrol acetate on weight loss induced by tumour necrosis factor alpha and a cachexia-inducing tumour (MAC16) in NMRI mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Recent clinical experience with dronabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Nutritional issues in cancer management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Preoperative insulin reverses cachexia and decreases mortality in tumor-bearing rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Humoral mediation for cachexia in tumour-bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Effect of insulin on weight loss and tumour growth in a cachexia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Workshop report. Psychopharmacologic applications to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Cytokine mediators of malnutrition: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Cytokines and glucocorticoids in the regulation of the "hepato-skeletal muscle axis" in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Total parenteral nutrition prevents further nutritional deterioration in patients with cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Total parenteral nutrition and cancer clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Metabolic effects of tumour necrosis factor-alpha (cachectin) and interleukin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Interleukin-15: a novel anabolic cytokine for skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Actions of insulin-like growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Hormonal control of muscle growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Insulinlike growth factor 1 production is inhibited in human sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Growth hormone, insulin, and somatostatin therapy of cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Mechanism of lipid mobilization associated with cancer cachexia: interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotide-regulatory protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Branched chain amino acids as the protein component of parenteral nutrition in cancer cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Brain tryptophan and the neoplastic anorexia-cachexia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

The Early Cancer Anorexia Paradigm: Changes in Plasma Free Tryptophan and Feeding Indexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Amino acid metabolism in tumour-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

From laboratory to bedside: new strategies in the treatment of malnutrition in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

A review of cancer cachexia and abnormal glucose metabolism in humans with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Effect of hydrazine sulphate on whole-body protein breakdown measured by 14C-lysine metabolism in lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

9-Deoxy-delta 9, delta 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Cancer growth, response to treatment and survival time in mice: Beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Prostaglandin secretion by medullary carcinoma of the thyroid. A possible cause of the associated idarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

The effects of cyclooxygenase inhibitors on tumor-induced anorexia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

5?-Deoxy-5-fluorouridine improves cachexia by a mechanism independent of its antiproliferative action in colon 26 adenocarcinoma-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Pharmacological agents affecting emesis. A review (Part I)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Anti-interferon-γ antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Megestrol acetate stimulates food and water intake in the rat: effects on regional hypothalamic neuropeptide Y concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Megestrol acetate in patients with AIDS-related cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Muscle hypercatabolism during cancer cachexia is not reversed by the glucocorticoid receptor antagonist RU38486

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Preoperative parenteral feeding in patients with gastrointestinal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Interleukin-1 receptor antagonist (IL-1ra) is unable to reverse cachexia in rats bearing an ascites hepatoma (Yoshida AH-130)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Murine interleukin-12 prevents the development of cancer cachexia in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Establishment and characterization of cachexia-inducing and -non-inducing clones of murine colon 26 carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Growth hormone stimulates protein synthesis during hypocaloric parenteral nutrition. Role of hormonal-substrate environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Growth hormone and insulin reverse net whole body and skeletal muscle protein catabolism in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Is there a role for melatonin in the treatment of neoplastic cachexia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical st

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Comparative effects of beta2-adrenergic agonists on muscle waste associated with tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Enhanced leucine oxidation in rats bearing an ascites hepatoma (Yoshida AH-130) and its reversal by clenbuterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Effects of dietary omega-3 fatty acids on human breast cancer growth and metastases in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Lack of effect of eicosapentaenoic acid in preventing cancer cachexia and inhibiting tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Improved protein kinetics and albumin synthesis by branched chain amino acid-enriched total parenteral nutrition in cancer cachexia. A prospective randomized crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Effects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Tumor regulation of hepatic glutamine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Glutamine Facilitates Chemotherapy While Reducing Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

Use of Hydrazine Sulfate in Terminal and Preterminal Cancer Patients: Results of Investigational New Drug (IND) Study in 84 Evaluable Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-1128%28200101%2921%3A1%3C83%3A%3AAID-MED4%3E3.0.CO%3B2-1

10.1002/1098-1128(200101)21:1<83::AID-MED4>3.0.CO;2-1

21 January 2018

Identifiers

DOI

1 reference

3 July 2017

1 reference